Picture of CareDx logo

CDNA — CareDx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

CareDx Inc reports results for the quarter ended in December - Earnings Summary

* CareDx Inc  CDNA.OQ  reported a quarterly adjusted loss
of 7
cents​​ per share for the quarter ended in December. The mean
expectation of seven analysts for the quarter was for a loss
of 9 cents per share.
    * Revenue rose 4% to $82.38 million from a year ago;
analysts
expected $81.66 million. 
    * CareDx Inc's reported EPS for the quarter was a loss of 34
cents​.
    * The mean earnings estimate of analysts had risen by
about 2% in
the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * CareDx Inc shares had risen by 26.6% this quarter.
    * The company reported a quarterly loss of $18.24 million.
    * Wall Street's median 12-month price target for CareDx Inc
is
$26.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
27 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.09          -0.07          Beat
 Sep. 30 2022      -0.14          -0.06          Beat
 Jun. 30 2022      -0.11          -0.13          Missed
 Mar. 31 2022      -0.05          -0.13          Missed

Recent news on CareDx

See all news